Literature DB >> 33781964

Current and New Next-Generation Sequencing Approaches to Study Mitochondrial DNA.

Andrea Legati1, Nadia Zanetti1, Alessia Nasca1, Camille Peron1, Costanza Lamperti1, Eleonora Lamantea1, Daniele Ghezzi2.   

Abstract

Mitochondria harbor multiple copies of a maternally inherited nonnuclear genome. Point mutations, deletions, or depletion of the mitochondrial DNA (mtDNA) are associated with various human diseases. mtDNA defects are currently studied using Sanger sequencing, Southern blot, and long and quantitative PCR. However, these technologies are expensive and are limited in speed, throughput, and sensitivity. Recently, next-generation sequencing (NGS) has been used to study mtDNA defects; however, its potential applications still need to be fully validated. We analyzed mtDNA from 16 control samples and 33 affected samples, which were previously investigated by traditional techniques. Different NGS approaches were tested, using classic library preparation based on PCR amplifications and an innovative PCR-free protocol, defining their suitability and utility for: i) generating full accurate mtDNA sequence, ii) assessing heteroplasmy for single point mutations with high accuracy, and iii) detecting break positions and heteroplasmy of single large deletions. This study confirmed that PCR-based library preparations are appropriate for the first two points and showed that a new PCR-free method gave the best results for the third aim. This study tested different approaches and describes an innovative PCR-free protocol, suitable for detection and heteroplasmy quantification of mtDNA single large deletions. NGS may become the method of choice for genetic analysis on mtDNA.
Copyright © 2021 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33781964     DOI: 10.1016/j.jmoldx.2021.03.002

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  4 in total

1.  Myopathic mitochondrial DNA depletion syndrome associated with biallelic variants in LIG3.

Authors:  Federica Invernizzi; Andrea Legati; Alessia Nasca; Eleonora Lamantea; Barbara Garavaglia; Mirjana Gusic; Robert Kopajtich; Holger Prokisch; Massimo Zeviani; Costanza Lamperti; Daniele Ghezzi
Journal:  Brain       Date:  2021-10-22       Impact factor: 15.255

2.  Leber's Hereditary Optic Neuropathy: A Report on Novel mtDNA Pathogenic Variants.

Authors:  Lorenzo Peverelli; Alessia Catania; Silvia Marchet; Paola Ciasca; Gabriella Cammarata; Lisa Melzi; Antonella Bellino; Roberto Fancellu; Eleonora Lamantea; Mariantonietta Capristo; Leonardo Caporali; Chiara La Morgia; Valerio Carelli; Daniele Ghezzi; Stefania Bianchi Marzoli; Costanza Lamperti
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

3.  Novel deep intronic mutation in PLA2G6 causing early-onset Parkinson's disease with brain iron accumulation through pseudo-exon activation.

Authors:  Ivano Di Meo; Valeria Tiranti; Chiara Cavestro; Celeste Panteghini; Chiara Reale; Alessia Nasca; Silvia Fenu; Ettore Salsano; Luisa Chiapparini; Barbara Garavaglia; Davide Pareyson
Journal:  Neurogenetics       Date:  2021-08-13       Impact factor: 2.660

4.  Biallelic Variants in ENDOG Associated with Mitochondrial Myopathy and Multiple mtDNA Deletions.

Authors:  Alessia Nasca; Andrea Legati; Megi Meneri; Melisa Emel Ermert; Chiara Frascarelli; Nadia Zanetti; Manuela Garbellini; Giacomo Pietro Comi; Alessia Catania; Costanza Lamperti; Dario Ronchi; Daniele Ghezzi
Journal:  Cells       Date:  2022-03-12       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.